Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Murine coronavirus infection: a paradigm for virus-induced demyelinating disease.

Literature DB >> 9025229

Murine coronavirus infection: a paradigm for virus-induced demyelinating disease.

Abstract

A variety of neurological diseases in humans, including multiple sclerosis (MS), have been postulated to have a viral etiology. The use of animal models provides insights into potential mechanism(s) involved in the disease process. The murine coronavirus-induced demyelinating disease in rodents is one such model for demyelinating disease in humans.

Entities: Disease Species

Mesh：

Year: 1997 PMID： 9025229 PMCID： PMC7133370 DOI： 10.1016/S0966-842X(97)81768-4

Source DB: PubMed Journal: Trends Microbiol ISSN： 0966-842X Impact factor: 17.079

55 in total

1. Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain.

Authors: F M Hofman; R I von Hanwehr; C A Dinarello; S B Mizel; D Hinton; J E Merrill
Journal: J Immunol Date: 1986-05-01 Impact factor: 5.422

2. Coronavirus infection induces H-2 antigen expression on oligodendrocytes and astrocytes.

Authors: A Suzumura; E Lavi; S R Weiss; D H Silberberg
Journal: Science Date: 1986-05-23 Impact factor: 47.728

3. Cytotoxic T cell-resistant variants are selected in a virus-induced demyelinating disease.

Authors: L Pewe; G F Wu; E M Barnett; R F Castro; S Perlman
Journal: Immunity Date: 1996-09 Impact factor: 31.745

4. Indirect evidence for nitric oxide involvement in multiple sclerosis by characterization of circulating antibodies directed against conjugated S-nitrosocysteine.

Authors: A I Boullerne; K G Petry; M Meynard; M Geffard
Journal: J Neuroimmunol Date: 1995-07 Impact factor: 3.478

5. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide.

Authors: J E Merrill; L J Ignarro; M P Sherman; J Melinek; T E Lane
Journal: J Immunol Date: 1993-08-15 Impact factor: 5.422

Review 6. Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus.

Authors: I Tsunoda; R S Fujinami
Journal: J Neuropathol Exp Neurol Date: 1996-06 Impact factor: 3.685

7. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro.

Authors: K W Selmaj; C S Raine
Journal: Ann Neurol Date: 1988-04 Impact factor: 10.422

8. Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated.

Authors: F I Wang; S A Stohlman; J O Fleming
Journal: J Neuroimmunol Date: 1990-11 Impact factor: 3.478

9. Coronavirus induction of class I major histocompatibility complex expression in murine astrocytes is virus strain specific.

Authors: W Gilmore; J Correale; L P Weiner
Journal: J Exp Med Date: 1994-09-01 Impact factor: 14.307

10. Mouse hepatitis virus A59-induced demyelination can occur in the absence of CD8+ T cells.

Authors: J L Gombold; R M Sutherland; E Lavi; Y Paterson; S R Weiss
Journal: Microb Pathog Date: 1995-03 Impact factor: 3.738

62 in total

1. Cytotoxic T-cell-resistant variants arise at early times after infection in C57BL/6 but not in SCID mice infected with a neurotropic coronavirus.

Authors: L Pewe; S Xue; S Perlman
Journal: J Virol Date: 1997-10 Impact factor: 5.103

2. Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design.

Authors: Mitchell R Emerson; Ryan J Gallagher; Janet G Marquis; Steven M LeVine
Journal: Comp Med Date: 2009-04 Impact factor: 0.982

3. Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron cryomicroscopy.

Authors: Benjamin W Neuman; Brian D Adair; Craig Yoshioka; Joel D Quispe; Gretchen Orca; Peter Kuhn; Ronald A Milligan; Mark Yeager; Michael J Buchmeier
Journal: J Virol Date: 2006-08 Impact factor: 5.103

4. A paradigm for virus-induced demyelinating disease.

Authors: T Christensen
Journal: Trends Microbiol Date: 1997-04 Impact factor: 17.079

Review 5. Cell replacement therapies to promote remyelination in a viral model of demyelination.

Authors: Emanuele Tirotta; Kevin S Carbajal; Chris S Schaumburg; Lucia Whitman; Thomas E Lane
Journal: J Neuroimmunol Date: 2010-06-02 Impact factor: 3.478

6. Functional expression of chemokine receptor CCR5 on CD4(+) T cells during virus-induced central nervous system disease.

Authors: William G Glass; Thomas E Lane
Journal: J Virol Date: 2003-01 Impact factor: 5.103